ARTV
Artiva Biotherapeutics
ARTV
ARTV
34 hedge funds and large institutions have $72.7M invested in Artiva Biotherapeutics in 2025 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 15 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 12
73% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 15
Holders
34
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$470K | |
| 2 | +$328K | |
| 3 | +$300K | |
| 4 |
Jane Street
New York
|
+$154K |
| 5 |
Renaissance Technologies
New York
|
+$140K |
Top Sellers
| 1 | -$2.29M | |
| 2 | -$1.89M | |
| 3 | -$446K | |
| 4 |
BlackRock
New York
|
-$309K |
| 5 |
Citigroup
New York
|
-$303K |
